CXCL10 and systemic sclerosis: We showed that CXCL10 serum level was significantly lower in SSc patients taking sildenafil compared to SSc patients on no sildenafil (455.2 ± 206.1 pg/mL vs. 633.1 ± 183 pg/mL, p < 0.05).